• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠球菌血症:临床特征、心内膜炎风险及管理

Enterococcal bacteremia: clinical features, the risk of endocarditis, and management.

作者信息

Maki D G, Agger W A

机构信息

Department of Medicine, University of Wisconsin Medical School, Madison.

出版信息

Medicine (Baltimore). 1988 Jul;67(4):248-69.

PMID:3134590
Abstract

The enterococci, members of the group D streptococci and the predominant aerobic streptococci of the gastrointestinal and female genital tracts, have long been recognized as significant pathogens in infective endocarditis. Over the past 2 decades, enterococci have become increasingly important nosocomial pathogens, related to their intrinsic resistance to many antibiotics, especially the cephalosporins, and the greatly increased use of antimicrobial therapy in hospitals. Recent reports have documented an alarming increase in the frequency of high-level resistance to aminoglyclosides, and strains resistant to ampicillin by production of a beta-lactamase and to vancomycin have now been encountered. We have reviewed the clinical features and course of 153 cases of enterococcal bacteremia occurring in a university hospital over the 14-year period, 1970 to 1983, 1) to understand better the importance of enterococci as human pathogens, 2) to identify the clinical features of enterococcal bacteremia, 3) to isolate those findings that help to identify associated endocarditis, and 4) to develop guidelines for more effective antimicrobial therapy of bacteremic enterococcal infections. The annual incidence of enterococcal bacteremia in our center rose three-fold over the period reviewed. In 65 cases (42%), bacteremia was polymicrobial, caused by Enterococcus and at least 1 other microorganism, usually an aerobic gram-negative bacillus. Most bacteremias were nosocomial and derived from infections of the urinary tract (29 cases), intravenous catheters (24 cases), intra-abdominal infections or surgical wounds (46 cases), burn wounds (25 cases), or cholangitis (21 cases); only 1 case originated from a pneumonia. Endocarditis was identified in association with 12 of 35 community-acquired bacteremias, but only 1 of 118 bacteremias acquired in the hospital (P less than .001). Endocarditis was also significantly associated with pre-existent valvular heart disease and cryptogenic bacteremia, and was negatively associated with polymicrobial enterococcal bacteremia (no endocarditis in 65 cases, P less than .001). Isolated enterococcal bacteremia produced an indolent infection rarely associated with shock (3 of 64 cases evaluated, all cases due to valve destruction by endocarditis); conversely, with polymicrobial enterococcal bacteremia, primarily with gram-negative bacilli, shock or disseminated intravascular coagulation developed in 50% of cases (P less than .001).(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

肠球菌是D组链球菌的成员,是胃肠道和女性生殖道中占主导地位的需氧链球菌,长期以来一直被认为是感染性心内膜炎的重要病原体。在过去20年中,肠球菌已成为日益重要的医院内病原体,这与其对许多抗生素(尤其是头孢菌素)的固有耐药性以及医院中抗菌治疗的大量增加有关。最近的报告记录了对氨基糖苷类高水平耐药频率的惊人增加,并且现已发现通过产生β-内酰胺酶对氨苄西林耐药以及对万古霉素耐药的菌株。我们回顾了1970年至1983年这14年间在一所大学医院发生的153例肠球菌血症的临床特征和病程,1)以便更好地了解肠球菌作为人类病原体的重要性,2)确定肠球菌血症的临床特征,3)找出有助于识别相关心内膜炎的那些发现,4)制定更有效的抗菌治疗肠球菌血症感染的指南。在我们中心,在所审查的期间内肠球菌血症的年发病率增加了两倍。在65例(42%)中,菌血症是多微生物性的,由肠球菌和至少1种其他微生物引起,通常是需氧革兰氏阴性杆菌。大多数菌血症是医院内感染,源自尿路感染(29例)、静脉导管感染(24例)、腹腔内感染或手术伤口感染(46例)、烧伤伤口感染(25例)或胆管炎(21例);只有1例源自肺炎。在35例社区获得性菌血症中有12例与心内膜炎相关,但在医院获得的118例菌血症中只有1例(P<0.001)。心内膜炎也与先前存在的瓣膜性心脏病和隐源性菌血症显著相关,并且与多微生物性肠球菌血症呈负相关(65例中无心内膜炎,P<0.001)。孤立性肠球菌血症产生的感染进展缓慢,很少与休克相关(在64例评估病例中有3例,所有病例均因心内膜炎导致瓣膜破坏);相反,对于多微生物性肠球菌血症,主要是与革兰氏阴性杆菌相关,50%的病例发生休克或弥散性血管内凝血(P<0.001)。(摘要截取自400字)

相似文献

1
Enterococcal bacteremia: clinical features, the risk of endocarditis, and management.肠球菌血症:临床特征、心内膜炎风险及管理
Medicine (Baltimore). 1988 Jul;67(4):248-69.
2
Risk factors for infective endocarditis in patients with enterococcal bacteremia: a case-control study.肠球菌血症患者感染性心内膜炎的危险因素:一项病例对照研究。
Infection. 2004 Apr;32(2):72-7. doi: 10.1007/s15010-004-2036-1.
3
[Enterococcal endocarditis: a multicenter study of 76 cases].[肠球菌性心内膜炎:76例多中心研究]
Enferm Infecc Microbiol Clin. 2009 Dec;27(10):571-9. doi: 10.1016/j.eimc.2009.02.007. Epub 2009 May 24.
4
Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.耐万古霉素肠球菌血症:粪肠球菌和屎肠球菌临床特征及结局的比较
J Microbiol Immunol Infect. 2008 Apr;41(2):124-9.
5
E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin.粪肠球菌万古霉素敏感型肠球菌菌血症,对万古霉素耐受菌株无反应,经高剂量达托霉素成功治疗。
Heart Lung. 2007 Nov-Dec;36(6):456-61. doi: 10.1016/j.hrtlng.2007.02.012.
6
Aminoglycoside resistant enterococcal endocarditis.耐氨基糖苷类肠球菌性心内膜炎
Infect Dis Clin North Am. 1993 Mar;7(1):117-33.
7
Enterococcus faecalis endocarditis.粪肠球菌性心内膜炎
Saudi Med J. 2002 Sep;23(9):1120-3.
8
Optimizing therapy for vancomycin-resistant enterococci (VRE).优化耐万古霉素肠球菌(VRE)的治疗方法。
Semin Respir Crit Care Med. 2007 Dec;28(6):632-45. doi: 10.1055/s-2007-996410.
9
Enterococcal bacteremia without endocarditis.无心内膜炎的肠球菌血症
Arch Intern Med. 1981 Apr;141(5):578-81.
10
Enterococcal meningitis: a clinical study of 39 cases and review of the literature.肠球菌性脑膜炎:39例临床研究及文献复习
Medicine (Baltimore). 2003 Sep;82(5):346-64. doi: 10.1097/01.md.0000090402.56130.82.

引用本文的文献

1
The MEFIER Score-A Risk Score to Stratify Infective Endocarditis in Patients With Bacteremia Based on an 11-Year Territory-Wide Cohort.MEFIER评分——一种基于11年全地区队列研究对菌血症患者感染性心内膜炎进行分层的风险评分。
Open Forum Infect Dis. 2025 May 12;12(6):ofaf287. doi: 10.1093/ofid/ofaf287. eCollection 2025 Jun.
2
From Gut to Heart: A Case Report of Infectious Endocarditis Stemming From Cholecystitis-Induced Enterococcus faecium Bacteremia.从肠道到心脏:一例由胆囊炎诱发粪肠球菌菌血症所致感染性心内膜炎的病例报告
Cureus. 2024 Apr 21;16(4):e58683. doi: 10.7759/cureus.58683. eCollection 2024 Apr.
3
Use of Biomaterials in 3D Printing as a Solution to Microbial Infections in Arthroplasty and Osseous Reconstruction.
生物材料在3D打印中的应用作为关节置换术和骨重建中微生物感染问题的解决方案
Biomimetics (Basel). 2024 Mar 1;9(3):154. doi: 10.3390/biomimetics9030154.
4
Bacteraemia caused by non-faecalis and non-faecium Enterococcus species-a retrospective study of incidence, focus of infection, and prognosis.非粪肠球菌和屎肠球菌属肠球菌引起的菌血症-发病率、感染焦点和预后的回顾性研究。
Eur J Clin Microbiol Infect Dis. 2024 Jan;43(1):45-53. doi: 10.1007/s10096-023-04690-x. Epub 2023 Nov 3.
5
Antimicrobial Properties of Capsaicin: Available Data and Future Research Perspectives.辣椒素的抗菌特性:现有数据与未来研究展望
Nutrients. 2023 Sep 22;15(19):4097. doi: 10.3390/nu15194097.
6
Recurrent bacteremia with Enterococcus faecalis, the clinical findings predicting endocarditis, and genomic characterization of the isolates: a retrospective cohort study.反复肠球菌属粪肠球菌菌血症,预测心内膜炎的临床发现,以及分离株的基因组特征:一项回顾性队列研究。
Eur J Clin Microbiol Infect Dis. 2023 Aug;42(8):1001-1009. doi: 10.1007/s10096-023-04636-3. Epub 2023 Jul 8.
7
Revision of the Diagnostic Criteria for Infective Endocarditis Is Needed-Please Do It Thoroughly.感染性心内膜炎诊断标准需要修订——请全面进行修订。
Clin Infect Dis. 2023 Jun 8;76(11):2041-2042. doi: 10.1093/cid/ciad120.
8
Kaempferol: Antimicrobial Properties, Sources, Clinical, and Traditional Applications.山奈酚:抗菌特性、来源、临床应用和传统应用。
Int J Mol Sci. 2022 Nov 30;23(23):15054. doi: 10.3390/ijms232315054.
9
CroR Regulates Expression of to Promote Cephalosporin Resistance in Enterococcus faecalis.克罗(Cro)调节 的表达,促进粪肠球菌对头孢菌素类药物的耐药性。
mBio. 2022 Aug 30;13(4):e0111922. doi: 10.1128/mbio.01119-22. Epub 2022 Aug 1.
10
Enterococcus faecalis bacteremia, cardiac implantable electronic device, extraction, and the risk of recurrence.粪肠球菌菌血症、心脏植入式电子设备、取出和复发风险。
Infection. 2022 Dec;50(6):1517-1523. doi: 10.1007/s15010-022-01838-3. Epub 2022 May 10.